Moderna’s COVID Vaccine Could Be Better Than Pfizer’s — Here’s Why Its Stock Isn’t
The numbers are in. And they look really good for Moderna(NASDAQ:MRNA).
On Sept. 17, the Centers for Disease Control and Prevention (CDC) released interim data that compared the effectiveness of the three COVID-19 vaccines on the market in the U.S. Moderna’s…
